Inside-out: unpredicted Annexin A2 localisation on the surface of extracellular vesicles
View / Open Files
Authors
Stewart, Sarah
Gessler, Florian
Pluchino, Stefano
Moreau, Kevin
Publication Date
2016-02-24Journal Title
Matters
Publisher
Science Matters
Language
English
Type
Article
Metadata
Show full item recordCitation
Stewart, S., Gessler, F., Pluchino, S., & Moreau, K. (2016). Inside-out: unpredicted Annexin A2 localisation on the surface of extracellular vesicles. Matters https://www.sciencematters.io/articles/201602000015
Description
This is the author accepted manuscript. The final version is available from Science Matters via https://www.sciencematters.io/articles/201602000015
Abstract
Inside-out: unpredicted Annexin A2 localisation on the surface of extracellular vesicles Extracellular vesicles (EVs) contain many proteins, both cytosolic and surface bound. The current model for EV biogenesis dictates that cytosolic proteins remain in the lumen and cell surface proteins reside on the outside of vesicles. This is consistent with the traditional protein trafficking pathway, where proteins destined for the plasma membrane contain a signal sequence targeting them to the secretory pathway. According to this ‘classical’ pathway for membrane and secretory protein trafficking, proteins lacking a signal sequence should not reside at the cell surface. It has been shown that transmembrane proteins are retained in the membrane of EVs and RNAs reside in the lumen of EVs. However, there is little known about the packaging and location of other proteins enriched in EVs. Annexin A2 is a cytosolic protein abundant in EVs. We show for the first time that Annexin A2 is expressed not only in the lumen of EVs as predicted but also on the surface of EVs. This raises fundamental questions regarding Annexin A2 transport to the outer leaflet of the EV membrane as it lacks a signal peptide for secretion.
Sponsorship
This work was supported by Wellcome Trust Strategic Award [100574/Z/12/Z] and MRC Metabolic Diseases Unit [MRC_MC_UU_12012/5], from the Italian Multiple Sclerosis Association (AISM, grant 2010/R/31), the Italian Ministry of Health (GR08-7), the European Research Council (ERC) under the ERC-2010-StG Grant agreement n° 260511-SEM_SEM, the UK Regenerative Medicine Platform Acellular hub (Partnership award RG69889), and core support grant from the Wellcome Trust and MRC to the Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute. FG is supported by a scholarship of the Gates Cambridge Trust.
Identifiers
External link: https://www.sciencematters.io/articles/201602000015
This record's URL: https://www.repository.cam.ac.uk/handle/1810/254582
Rights
Attribution 2.0 UK: England & Wales
Licence URL: http://creativecommons.org/licenses/by/2.0/uk/
Recommended or similar items
The following licence files are associated with this item: